BNP Paribas Financial Markets’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$546K Buy
159,677
+74,096
+87% +$230K ﹤0.01% 3709
2026
Q1
$195K Sell
85,581
-368,543
-81% -$849K ﹤0.01% 4067
2025
Q4
$1.27M Buy
454,124
+194,207
+75% +$694K ﹤0.01% 2937
2025
Q3
$1.25M Buy
259,917
+192,608
+286% +$1.23M ﹤0.01% 2974
2025
Q2
$613K Sell
67,309
-50,863
-43% -$375K ﹤0.01% 3197
2025
Q1
$1.07M Buy
118,172
+105,939
+866% +$1.12M ﹤0.01% 2740
2024
Q4
$160K Sell
12,233
-19,948
-62% -$266K ﹤0.01% 3983
2024
Q3
$505K Buy
32,181
+7,830
+32% +$119K ﹤0.01% 2852
2024
Q2
$329K Sell
24,351
-23,236
-49% -$476K ﹤0.01% 2866
2024
Q1
$1.32M Buy
47,587
+25,779
+118% +$572K ﹤0.01% 2320
2023
Q4
$420K Sell
21,808
-2,460
-10% -$44.6K ﹤0.01% 2886
2023
Q3
$392K Buy
24,268
+2,091
+9% +$37.1K ﹤0.01% 2852
2023
Q2
$422K Sell
22,177
-18,436
-45% -$329K ﹤0.01% 2671
2023
Q1
$591K Buy
40,613
+19,301
+91% +$346K ﹤0.01% 2637
2022
Q4
$416K Sell
21,312
-15,352
-42% -$299K ﹤0.01% 2685
2022
Q3
$884K Buy
36,664
+7,590
+26% +$234K ﹤0.01% 2590
2022
Q2
$914K Sell
29,074
-1,849
-6% -$67K ﹤0.01% 2258
2022
Q1
$1.36M Sell
30,923
-10,058
-25% -$432K ﹤0.01% 2104
2021
Q4
$1.78M Sell
40,981
-54,438
-57% -$2.13M ﹤0.01% 2139
2021
Q3
$2.99M Buy
95,419
+41,004
+75% +$1.61M ﹤0.01% 1630
2021
Q2
$2.3M Buy
54,415
+3,818
+8% +$149K ﹤0.01% 1691
2021
Q1
$1.9M Buy
50,597
+21,474
+74% +$671K ﹤0.01% 1706
2020
Q4
$788K Sell
29,123
-5,357
-16% -$138K ﹤0.01% 2188
2020
Q3
$866K Sell
34,480
-566
-2% -$8.25K ﹤0.01% 1888
2020
Q2
$267K Buy
35,046
+6,318
+22% +$46.2K ﹤0.01% 2375
2020
Q1
$263K Buy
28,728
+2,753
+11% +$16.6K ﹤0.01% 2718
2019
Q4
$134K Buy
25,975
+12,183
+88% +$78.2K ﹤0.01% 3149
2019
Q3
$80.1K Sell
13,792
-8,625
-38% -$38.7K ﹤0.01% 3236
2019
Q2
$71.7K Sell
22,417
-2,147
-9% -$7.32K ﹤0.01% 3222
2019
Q1
$101K Buy
24,564
+9,333
+61% +$59K ﹤0.01% 3123
2018
Q4
$96.4K Buy
15,231
+1,124
+8% +$11.7K ﹤0.01% 2382
2018
Q3
$233K Sell
14,107
-9,116
-39% -$155K ﹤0.01% 2343
2018
Q2
$388K Sell
23,223
-4,052
-15% -$65.6K ﹤0.01% 2120
2018
Q1
$424K Sell
27,275
-13,529
-33% -$241K ﹤0.01% 2328
2017
Q4
$770K Buy
40,804
+6,240
+18% +$138K ﹤0.01% 2165
2017
Q3
$1.01M Sell
34,564
-9,255
-21% -$273K ﹤0.01% 1553
2017
Q2
$1.41M Buy
43,819
+25,263
+136% +$829K ﹤0.01% 1368
2017
Q1
$642K Sell
18,556
-7,605
-29% -$272K ﹤0.01% 1600
2016
Q4
$923K Buy
26,161
+12,452
+91% +$421K ﹤0.01% 1372
2016
Q3
$476K Sell
13,709
-20,791
-60% -$728K ﹤0.01% 1245
2016
Q2
$1.29M Buy
34,500
+33,339
+2,872% +$1.25M 0.01% 1066
2016
Q1
$46.9K Sell
1,161
-32,853
-97% -$1.22M ﹤0.01% 2016
2015
Q4
$1.22M Buy
34,014
+21,534
+173% +$779K ﹤0.01% 1058
2015
Q3
$399K Sell
12,480
-2,135
-15% -$72.7K ﹤0.01% 1490
2015
Q2
$497K Buy
14,615
+1,863
+15% +$62.8K ﹤0.01% 1344
2015
Q1
$432K Buy
+12,752
New +$444K ﹤0.01% 1361
2014
Q4
Sell
-24,482
Closed -$802K 2829
2014
Q3
$802K Buy
24,482
+8,110
+50% +$276K ﹤0.01% 1340
2014
Q2
$556K Sell
16,372
-616
-4% -$21.1K ﹤0.01% 1448
2014
Q1
$570K Buy
16,988
+15,041
+773% +$531K ﹤0.01% 1376
2013
Q4
$71.2K Sell
1,947
-15,121
-89% -$555K ﹤0.01% 1786
2013
Q3
$590K Sell
17,068
-5,059
-23% -$177K ﹤0.01% 1434
2013
Q2
$749K Buy
+22,127
New +$734K ﹤0.01% 1218

Other funds holding ACH

BNP Paribas Financial Markets's ACH Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Accendra Health (ACH) stake by 87% in Q2 2026, buying an estimated $230K and bringing the position to 159,677 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #3709.

BNP Paribas Financial Markets first reported a position in ACH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.99M in Q3 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • BNP Paribas Financial Markets held 159,677 shares of Accendra Health worth $546K as of Q2 2026.
  • BNP Paribas Financial Markets bought 74,096 Accendra Health shares in Q2 2026, an estimated $230K.
  • Accendra Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3709 holding.
  • BNP Paribas Financial Markets first reported a position in Accendra Health in Q2 2013 and has held it in 52 quarters since.
  • BNP Paribas Financial Markets's Accendra Health position peaked at $2.99M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.